Why Startups Scale Through a Sequence of Constraints
This series examines innovative start-ups founded in the European Union and the United States and asks why some become unusually large, fast-growing firms while most do not. Its focus is not startup creation in the abstract, but the passage from early innovative promise to advanced scale: the point at which a company must commercialise, raise much more capital, expand across markets, build a more capable organisation, and draw on an ecosystem that can reinforce its progress. The practical value of that focus is a better way to judge scale-up claims. A promising invention, a large funding round, and a billion-dollar valuation are related milestones, but they are not the same achievement.
Scaling Is Not One Threshold
The OECD study gives this problem a useful vocabulary. It calls a firm an innovative start-up if it has either filed for a patent or received venture-capital investment. That is an intentionally broad starting category: it identifies firms with observable signs of innovation or investor interest, not firms that have already demonstrated commercial success.
A growth-oriented start-up has raised at least USD 50 million without reaching the higher valuation category. A rising superstar has reached a valuation of at least USD 1 billion, either while private or at an initial public offering. The latter two groups are treated as scale-ups, but they represent different degrees of achievement. Raising substantial funding signals that investors see a route to growth. Reaching a billion-dollar valuation signals a much more demanding combination of market expectations, expansion potential, financing, and execution.
That distinction matters because scaling is not simply a larger version of starting. Early-stage work is dominated by experimentation: finding a problem worth solving, building a product, and testing whether customers will adopt it. Later growth creates different demands. The firm may need to protect and commercialise technical knowledge, sustain a much larger workforce, enter multiple markets, integrate acquisitions, and satisfy investors who must commit unusually large amounts of capital under uncertainty. Capabilities that help a company get noticed are not automatically the capabilities that let it expand.
The categories also need to be read carefully. The study assigns each start-up to the highest outcome it achieved during the sample period. It does not follow every company through a fully observed sequence from patent or first investment to funding threshold and then valuation. A firm classified as a rising superstar may have passed through intermediate stages, but the data structure does not turn that possibility into a complete, causal biography. The categories are best understood as markers of eventual outcomes that allow meaningful comparisons.
The upper tail deserves attention because the economic contribution of entrepreneurship is highly uneven. Only a small share of young firms achieves sustained high growth, yet those firms can have disproportionate effects on productivity, employment, research, competition, and knowledge diffusion. A policy that increases the number of new ventures may therefore miss a different problem: whether a small group with unusually strong potential can obtain the resources and time needed to become globally significant.
The Gap Is Not Simply a Shortage of Start-ups
The EU and the US both produce innovative start-ups, but their distributions of advanced outcomes differ sharply. In the OECD study’s principal comparison, the EU contains 59,820 innovative start-ups, 1,841 growth-oriented firms, and 358 rising superstars. The corresponding US counts are 118,459, 9,389, and 1,586. The absolute totals reflect the larger US population of firms in the database, but the proportions show where the difference becomes more pronounced: in the broader comparison of all recorded start-ups, innovative firms make up about 11.8% of the EU and 12.6% of the US, while growth-oriented firms make up 0.36% and 0.99%, and rising superstars 0.07% and 0.17%.
Those rare firms also command a striking share of resources. In both regions, roughly 12–13% of start-ups—the scaling and innovative groups together—account for around 80% of recorded start-up funding. Rising superstars alone represent less than one-fifth of one percent of start-ups in either location, yet receive a very large share of funding. This concentration changes the meaning of the scale-up gap. The issue is not merely whether Europe can produce ideas or launch companies. It is whether its institutions and markets can help a small number of firms cross increasingly expensive thresholds.
Time adds another dimension. EU rising superstars typically reach their scaling milestone about eight years after founding, compared with just over seven years in the US. Growth-oriented firms scale roughly a year earlier than rising superstars in both regions. A year is not a universal measure of failure, and the distributions include firms that take much longer. But delay matters when a market is changing quickly: it can extend the period over which a company must finance experimentation, comply with multiple rules, recruit people, and defend a position against faster rivals.
The comparison is not well explained by saying that the two regions simply specialise in different industries. ICT is the largest sectoral category across the start-up groups in both places, and health, biotechnology, professional services, and financial services are also important among rising superstars. The sector labels are descriptive and non-exclusive—one firm can belong to more than one category—so they are not a perfect industrial decomposition. Still, the broadly similar profiles make a structural question more important than a sectoral one: when firms face comparable opportunities, what allows some environments to convert those opportunities into scale more quickly and more reliably?
That question should not be turned into a simple ranking of Europe and America. The OECD evidence describes a persistent difference in outcomes and timing, not a claim that every US firm has an advantage or every European firm is constrained in the same way. The EU is an aggregate of countries with different institutions and ecosystems, and the database is assembled from commercial and administrative sources whose coverage varies. The comparison is valuable precisely because it points toward mechanisms while leaving room to test them.
A Sequence of Constraints
A useful way to read the evidence is as a sequence of constraints—not a fixed recipe, but a set of hurdles that become more demanding as a start-up grows.
The first hurdle is the translation of knowledge into a commercially usable position. Patenting provides one window into that process because it involves formal protection, administrative decisions, and the ability to operate across jurisdictions. The relevant question is not simply whether a firm invented something. It is whether innovation can be formalised, protected, financed, and brought to market without losing too much time.
The next hurdle is financial depth. Initial capital can support experimentation and first market entry. The most ambitious firms later need coordinated, risk-tolerant funding rounds large enough to expand organisations and markets. Investor networks matter here because they can contribute expertise, credibility, follow-on access, and international connections as well as money.
Market expansion creates a third demand. A company may grow organically, but acquisitions can sometimes provide faster access to customers, technology, talent, or geographic footholds. That route is not free: it requires integration capacity and can raise competition concerns. The strategic choice depends on what the firm is trying to obtain and whether it can absorb what it buys.
Then the organisation must catch up with its ambition. Serial entrepreneurial experience and advanced education are associated with scaling in the data, but later growth also brings a need for professional financial and managerial expertise. A founding team that can discover a product-market opportunity may need external executives to manage governance, capital mobilisation, and a far more complex operating system.
Finally, all of these inputs have to connect somewhere. A dense ecosystem can make it easier to find investors, skilled workers, research partners, suppliers, and future founders. It can also turn one firm’s success into a signal that attracts capital or encourages new innovative ventures. But that amplification is not automatic. A successful company can remain an isolated event if its relationships are thin, its resources are internationally detached, or its local environment lacks the capacity to respond.
This model keeps the subject—the innovative start-up and its changing relationship with the EU or US environment—in view. It also explains why no single statistic settles the question. A region can have inventive firms but slow commercialisation; early funding but shallow late-stage capital; strong founders but limited managerial depth; or a celebrated scale-up without broad local spillovers. These are not separate stories. They are different ways in which a firm can lose momentum while moving from promise to scale.
The central judgment for the rest of this series is therefore conditional: start-ups achieve advanced scale when they repeatedly overcome the constraint that matters at their current stage and can combine it with the next required capability. The first empirical task is to locate those bottlenecks precisely—starting with the difference between having an invention and turning it into commercial scale.